Skin cancer cells work together to spread further and faster, according to a new study published in Cell Reports. The discovery could lead to new drugs to tackle melanoma, the most deadly form of skin cancer.
MRV Research
New analysis method finds possible therapeutic targets for drug resistant melanoma
Researchers have developed a new way to identify possible therapeutic targets for patients with drug resistant melanoma. The technique, liquid chromatography-multiple reaction monitoring mass spectrometry, measures biomarkers or molecules in blood and tissue that indicates cancer is present. These measurements can help researchers determine if a patient is responding to treatment.
New approach identifies cancer mutations as targets of effective melanoma immunotherapy
A new approach demonstrated that the recognition of unique cancer mutations appeared to be responsible for complete cancer regressions in two metastatic melanoma patients treated with a type of immunotherapy called adoptive T-cell therapy. This new approach may help develop more effective cancer immunotherapies, according to a new study.
Piggybacking cells hold clue to cancer growth – and treatment for melanoma
Discovery of how fast growing tumour cells hitch ride on invasive cells could help create a new drug to tackle skin cancer